On the public citation graph

https://doi.org/10.2139/ssrn.4626754

0 signed · 33 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2016.0289openalex-extracted
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
inferredcites →https://doi.org/10.1002/hec.843openalex-extracted
Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data
inferredcites →https://doi.org/10.1002/hec.903openalex-extracted
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
inferredcites →https://doi.org/10.1002/sim.4067openalex-extracted
Multiple imputation using chained equations: Issues and guidance for practice
inferredcites →https://doi.org/10.1007/s00134-018-5134-8openalex-extracted
Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates
inferredcites →https://doi.org/10.1007/s10198-002-0095-8openalex-extracted
Burden of illness imposed by severe sepsis in Germany
inferredcites →https://doi.org/10.1007/s11136-011-9903-xopenalex-extracted
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
inferredcites →https://doi.org/10.1007/s40273-014-0193-3openalex-extracted
A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
inferredcites →https://doi.org/10.1007/s40273-015-0282-yopenalex-extracted
The Economic and Humanistic Burden of Severe Sepsis
inferredcites →https://doi.org/10.1016/j.jcrc.2004.10.005openalex-extracted
Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost
inferredcites →https://doi.org/10.1016/j.jinf.2016.11.006openalex-extracted
Hospital-related cost of sepsis: A systematic review
inferredcites →https://doi.org/10.1016/j.jval.2015.05.009openalex-extracted
The iMTA Productivity Cost Questionnaire
inferredcites →https://doi.org/10.1016/j.jval.2016.01.003openalex-extracted
Dutch Tariff for the Five-Level Version of EQ-5D
inferredcites →https://doi.org/10.1016/j.molmed.2014.01.007openalex-extracted
Why have clinical trials in sepsis failed?
inferredcites →https://doi.org/10.1016/s0140-6736(19)32989-7openalex-extracted
Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
inferredcites →https://doi.org/10.1016/s1473-3099(14)70036-2openalex-extracted
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
inferredcites →https://doi.org/10.1017/s0266462306050884openalex-extracted
Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom
inferredcites →https://doi.org/10.1038/s41467-018-04059-1openalex-extracted
Evolution of high-level resistance during low-level antibiotic exposure
inferredcites →https://doi.org/10.1086/379825openalex-extracted
Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial
inferredcites →https://doi.org/10.1093/cid/ciu027openalex-extracted
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
inferredcites →https://doi.org/10.1097/01.ccm.0000085178.80226.0bopenalex-extracted
Long-term mortality and medical care charges in patients with severe sepsis
inferredcites →https://doi.org/10.1097/ccm.0000000000000514openalex-extracted
Vancomycin-Associated Nephrotoxicity in the Critically Ill
inferredcites →https://doi.org/10.1136/bmj.321.7273.1362openalex-extracted
Economic evaluation and clinical trials: size matters
inferredcites →https://doi.org/10.1164/rccm.201609-1848ocopenalex-extracted
The Timing of Early Antibiotics and Hospital Mortality in Sepsis
inferredcites →https://doi.org/10.1177/0272989x9001000308openalex-extracted
The CE Plane
inferredcites →https://doi.org/10.1186/cc5952openalex-extracted
A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units
inferredcites →https://doi.org/10.1186/cc6116openalex-extracted
Cost-effectiveness of activated protein C in real-life clinical practice
inferredcites →https://doi.org/10.1186/s13054-019-2438-1openalex-extracted
Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study
inferredcites →https://doi.org/10.1186/s13054-022-04098-7openalex-extracted
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial
inferredcites →https://doi.org/10.1186/s13063-019-3911-5openalex-extracted
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock — rationale and design of a multicenter randomized controlled superiority trial
inferredcites →https://doi.org/10.2146/ajhp050214openalex-extracted
Evaluating the clinical and financial impact of severe sepsis with Medicare or other administrative hospital data
inferredcites →https://doi.org/10.3389/fphar.2020.00646openalex-extracted
Right Dose, Right Now: Development of AutoKinetics for Real Time Model Informed Precision Antibiotic Dosing Decision Support at the Bedside of Critically Ill Patients
inferredcites →https://doi.org/10.4414/smw.2004.10475openalex-extracted
Burden of illness imposed by severe sepsis in Switzerland
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.